TRADING UPDATES: Genflow patent progress; Accsys new debt facilities
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
| Price | 0.15p on 04-11-2025 at 19:35:12 |
|---|---|
| Change | -0.004p -2.6% |
| Buy | 0.16p |
| Sell | 0.14p |
| Last Trade: | Sell 853.00 at 0.1477p |
| Day's Volume: | 6,843,145 |
| Last Close: | 0.15p |
| Open: | 0.15p |
| ISIN: | GB00BF3DT583 |
| Day's Range | 0.15p - 0.15p |
| 52wk Range: | 0.13p - 1.65p |
| Market Capitalisation: | £1.81m |
| VWAP: | 0.150212p |
| Shares in Issue: | 1.21b |
Sector: Medical Services
Listed In: FTSE AIM All-Share,
polarean (POLX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 853 | 0.1477p | Ordinary |
15:46:39 - 04-Nov-25 |
| Sell* | 20,000 | 0.14p | Ordinary |
14:23:04 - 04-Nov-25 |
| Sell* | 352,878 | 0.1461p | Ordinary |
12:46:47 - 04-Nov-25 |
| Buy* | 971,835 | 0.158p | Ordinary |
12:40:47 - 04-Nov-25 |
| Sell* | 20,000 | 0.1471p | Ordinary |
12:28:44 - 04-Nov-25 |
| Buy* | 2,439,888 | 0.1518p | Ordinary |
12:11:08 - 04-Nov-25 |
| Sell* | 325,618 | 0.1461p | Ordinary |
10:24:00 - 04-Nov-25 |
| Sell* | 1,942 | 0.14p | SI Trade |
09:38:40 - 04-Nov-25 |
| Sell* | 2,196 | 0.14p | SI Trade |
09:38:40 - 04-Nov-25 |
| Sell* | 6,680 | 0.14p | SI Trade |
09:38:40 - 04-Nov-25 |
polarean (POLX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 27th Oct 2025 3:37 pm | RNS | Holding(s) in Company |
| 22nd Oct 2025 7:00 am | RNS | Strategic review and consideration of AIM listing |
| 6th Oct 2025 7:00 am | RNS | Ascend Imaging agreement expansion |
| 29th Sep 2025 7:00 am | RNS | University of Virginia Health Hospital agreement |
| 25th Sep 2025 12:14 pm | RNS | National Institutes of Health system order |
| 25th Sep 2025 7:00 am | RNS | Half-year Report |
| 16th Sep 2025 7:00 am | RNS | Notice of Results |
| 11th Sep 2025 4:36 pm | RNS | Holding(s) in Company |
| 12th Aug 2025 7:00 am | RNS | Submission of new Phase III study protocol to FDA |
| 24th Jul 2025 7:00 am | RNS | Block Listing Six Monthly Return |